Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Hong Kong
  4. Hong Kong Stock Exchange
  5. Hygeia Healthcare Holdings Co., Limited
  6. Financials
    6078   KYG4712E1035

HYGEIA HEALTHCARE HOLDINGS CO., LIMITED

(6078)
  Report
Delayed Hong Kong Stock Exchange  -  04:08 2022-09-30 am EDT
44.35 HKD   -5.54%
09/07Hygeia Healthcare Holdings Co., Limited acquired 30% of KAIYUAN JIEHUA HOSPITAL CO., LTD for CNY 15.3 million.
CI
09/06Hygeia Healthcare Strikes $2 Million Deal to Take Over Jiehua Hospital
MT
08/31Hygeia Healthcare Holdings Co., Limited Omits Dividend for the Six Months Ended June 30, 2022
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Valuation
Fiscal Period: December 2020 2021 2022 2023 2024
Capitalization1 25 38324 57324 788--
Enterprise Value (EV)2 22 80325 09825 04423 72322 293
P/E ratio 108x56,0x42,3x30,2x23,4x
Yield 0,29%-0,09%0,17%0,32%
Capitalization / Revenue 18,1x10,6x7,63x5,93x4,83x
EV / Revenue 16,3x10,8x7,71x5,67x4,34x
EV / EBITDA 60,4x35,4x26,2x18,6x14,3x
Price to Book 5,95x5,51x4,87x4,32x3,74x
Nbr of stocks (in thousands) 618 000618 000616 724--
Reference price (CNY) 41,139,840,240,240,2
Announcement Date 03/29/202103/30/2022---
1 HKD in Million
2 CNY in Million
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Net sales1 1 0861 4022 3153 2484 1835 135
EBITDA1 -3787089551 2781 562
Operating profit (EBIT)1 -3005947651 0351 217
Operating Margin -21,4%25,6%23,6%24,7%23,7%
Pre-Tax Profit (EBT)1 -2535737951 0501 350
Net income1 39,81704415948091 049
Net margin 3,66%12,1%19,1%18,3%19,3%20,4%
EPS2 -0,380,710,951,331,72
Dividend per Share2 -0,12-0,040,070,13
Announcement Date 06/16/202003/29/202103/30/2022---
1 CNY in Million
2 CNY
Estimates
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2022 S1 2022 S2 2023 S1 2023 S2
Net sales1 1 5261 8471 9402 371
EBITDA ----
Operating profit (EBIT)1 315432440538
Operating Margin 20,6%23,4%22,7%22,7%
Pre-Tax Profit (EBT) 307---
Net income 224---
Net margin 14,7%---
EPS ----
Dividend per Share ----
Announcement Date 08/31/2022---
1 CNY in Million
Estimates
Balance Sheet Analysis
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Net Debt1 --525256--
Net Cash position1 -2 580--1 0652 496
Leverage (Debt / EBITDA) --6,83x0,74x0,27x-0,83x-1,60x
Free Cash Flow1 --29,1-2435227921 449
ROE (Net Profit / Equities) -8,37%10,1%13,2%15,2%15,9%
Shareholders' equity1 -2 0334 3624 5085 3176 603
ROA (Net Profit / Asset) -4,92%7,75%9,00%11,3%12,3%
Assets1 -3 4575 6946 6017 1448 542
Book Value Per Share2 -6,917,218,259,3010,7
Cash Flow per Share2 -0,660,691,221,661,53
Capex1 -325669538413360
Capex / Sales -23,2%28,9%16,6%9,87%7,01%
Announcement Date 06/16/202003/29/202103/30/2022---
1 CNY in Million
2 CNY
Estimates
Key data
Capitalization (HKD) 27 351 718 270
Capitalization (USD) 3 484 317 514
Net sales (CNY) 2 315 349 000
Net sales (USD) 325 450 009
Number of employees 5 466
Sales / Employee (CNY) 423 591
Sales / Employee (USD) 59 541
Free-Float 54,5%
Free-Float capitalization (HKD) 14 914 697 974
Free-Float capitalization (USD) 1 899 973 627
Avg. Exchange 20 sessions (CNY) 165 456 075
Avg. Exchange 20 sessions (USD) 23 256 831
Average Daily Capital Traded 0,60%
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA